News
ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Process of US$36 Million
ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
ESSA Pharma Provides Corporate Update and Reports Financial Results for the Fiscal Third Quarter Ended June 20, 2019
ESSA Announces that the Scheme of Arrangement with Realm Therapeutics has become Effective
ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics
ESSA Expands Leadership Team by Appointing Alessandra Cesano as Chief Medical Officer
ESSA Provides Update on Court Hearing
ESSA Provides Update to the Acquisition of Realm Therapeutics
ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders
ESSA Pharma to Hold Annual Shareholders’ Meeting and Announces Three Realm-Nominated Directors